Science & Research

Philadelphia District Laboratory (PHI)


FY 10 Analysts On Board: 18

FY 10 Samples Analyzed: 984

Program Capabilities

PHI-DO Pharmaceutical Laboratory specializes in the analyses of all forms and types of drug products.Its work involves nearly all phases of drug analysis and review, including the following programs:

  • New Drug Applications
  • Abbreviated New Drug Applications
  • Drug compliance and complaint samples
  • Department of Defense Shelf-Life Extension Program samples
  • Drug surveillance programs
  • Over-the-Counter and fraudulent drug samples
  • Method assessment of compendial drugs
  • Drug Quality Reporting System samples
  • Domestic inspections of pharmaceutical and veterinary drug firms
  • International inspections of pharmaceutical and veterinary drug firms
  • Inspections of contract testing laboratories
  • In-vitro biopharmaceutical research samples

Specialized Capabilities

PHI-DO Pharmaceutical Laboratory also has the unique capability of testing pressurized topical aerosols, metered-dose inhalers and propellant-free dry powder inhalers used to aerosolize, or to aerosolize and meter, doses of powder for inhalation. This includes metered-dose inhalers (breath-actuated or dose-metering nebulizers) formulated as suspensions or solutions of active drug in propellants and dry powder inhalers marketed as single- or multi-dose units.

High Throughput for Drug Analysis

PHI-DO Laboratory has recently increased its mass spectroscopy capabilities to allow for the inclusion of screening for Toxins and Poisons, and PDE 5 Inhibitors using the LCMS and screening for weight loss drugs in dietary supplements using GCMS.

Page Last Updated: 07/14/2015
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English